DRAKON

Worldwide Angiography Equipment Industry to 2028 - by Device, Procedure, End-users and Region - ResearchAndMarkets.com

Retrieved on: 
Monday, October 17, 2022
Radiology, Health Technology, Health, Adoption, St. Jude Medical, Growth, Abbott Laboratories, Hospital, DRAKON, Research, Guerbet, GE Healthcare, Cardiac catheterization, Fluorescein angiography, Magnetic resonance angiography, Computed tomography angiography, Philips, Digital, Boston Scientific, Medtronic, Medical imaging

The global angiography equipment market is segmented based on the device, procedure, and end-users.

Key Points: 
  • The global angiography equipment market is segmented based on the device, procedure, and end-users.
  • Based on the device, the market is segmented into angiography systems, computed tomography angiography, digital subtraction angiography, magnetic resonance angiography, catheters tube, guide wires, balloons, and others including vascular closure devices and other accessories.
  • Based on the procedure, the market is sub-segmented into coronary angiography, fluorescein angiography, microangiography, neuro-vascular angiography, and peripheral angiography.
  • Geographically the global angiography equipment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.

Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization

Retrieved on: 
Monday, March 7, 2022
Euronext Paris, Patient, Research, VP, IIB, NSAI, GBT, FDA, Solution, DRAKON, Therapy, Sale, Agent handling, Senior, Acquisition, EC, Law of the United States, CE, PCI, Technology, AI, Physician, III, Radiology, Guidewire Software, Medical imaging, Pharmaceutical industry, Medical device, EU, Guerbet

VILLEPINTE, France, March 7, 2022 /PRNewswire/ -- Guerbet (FR0000032526 GBT), a global leader in medical imaging, announcesit will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available.

Key Points: 
  • VILLEPINTE, France, March 7, 2022 /PRNewswire/ -- Guerbet (FR0000032526 GBT), a global leader in medical imaging, announcesit will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available.
  • Guerbet now expands the portfolio, adding 20 versions for a total of 38, and launching a new line of Axessio guidewires with two diameters.
  • With strategic acquisitions that helped create a unique toolkit of microcatheters and this latest portfolio extension, we're advancing options for the interventional radiology community."
  • We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging.

Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization

Retrieved on: 
Monday, March 7, 2022
Euronext Paris, Patient, Research, VP, IIB, NSAI, GBT, FDA, Solution, DRAKON, Therapy, Sale, Agent handling, Senior, Acquisition, EC, Law of the United States, CE, PCI, Technology, AI, Physician, III, Radiology, Guidewire Software, Medical imaging, Pharmaceutical industry, Medical device, EU, Guerbet

VILLEPINTE, France, March 7, 2022 /PRNewswire/ -- Guerbet (FR0000032526 GBT), a global leader in medical imaging, announcesit will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available.

Key Points: 
  • VILLEPINTE, France, March 7, 2022 /PRNewswire/ -- Guerbet (FR0000032526 GBT), a global leader in medical imaging, announcesit will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available.
  • Guerbet now expands the portfolio, adding 20 versions for a total of 38, and launching a new line of Axessio guidewires with two diameters.
  • With strategic acquisitions that helped create a unique toolkit of microcatheters and this latest portfolio extension, we're advancing options for the interventional radiology community."
  • We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging.